AOD-9604 benefits and side effects explained: what research shows about fat loss, dosing, safety, and why the peptide is not FDA-approved.
AOD-9604 is a synthetic fragment of human growth hormone (hGH 176-191) that researchers have studied mainly for fat loss. Small human trials reported modest reductions in body fat with generally mild side effects, but the peptide is not FDA-approved for human use in the United States and is sold only as a research chemical. Anyone considering it should know that the evidence base is thin and that purity and labeling vary widely between suppliers.
What Is AOD-9604?
AOD-9604 is a 16-amino-acid piece of the growth hormone molecule, taken from the region scientists once believed drove fat metabolism rather than growth. Because it is only a fragment, it does not appear to trigger the broad growth and metabolic signals of full-length hGH.
That difference matters. Full growth hormone raises IGF-1, affects insulin sensitivity, and can cause fluid retention and joint pain. AOD-9604 was designed to isolate lipolytic activity, meaning the breakdown of stored fat, without those wider actions.
In laboratory work, the peptide stimulates lipolysis in fat cells and has been reported to limit new fat formation in some models. Human data remain limited to a few small trials, and the aod 9604 effects reported there were modest rather than dramatic.
Potential Benefits of AOD-9604
Fat loss and body composition
The most studied claim is fat reduction. A randomized trial in obese adults found that daily injections produced greater fat loss than placebo over 12 weeks, but the difference was small and the study did not measure long-term outcomes. A separate trial in obese men reported similar, limited results.
Some animal research suggests the peptide may reduce fat accumulation and improve certain metabolic markers, though animal findings do not always carry over to people.
Cartilage and joint research
Separate laboratory work has explored AOD-9604 for cartilage repair, since the hGH fragment appears to stimulate cartilage cells in some models. This research is early, and no study has shown that AOD-9604 regrows cartilage in humans.
Reported Side Effects and Safety Concerns
In published human trials, AOD-9604 was generally well tolerated. The most commonly reported issues were mild and temporary.
- Injection-site redness, pain, or swelling
- Headache
- Nausea or upset stomach
- Fatigue
- Possible allergic reaction, including rash or hives
Because AOD-9604 is not an approved drug, no manufacturer has completed the large, long-term safety studies the FDA requires. Effects on hormone balance, blood sugar, and immune response over months or years are unknown. Peptides bought online may also be mislabeled, underdosed, or contaminated, which adds risk that has nothing to do with the molecule itself.
| Claimed benefit | Evidence level | What studies show |
|---|---|---|
| Fat loss | Small human trials | Modest reductions versus placebo over 12 weeks |
| Cartilage repair | Lab and animal only | No confirmed human benefit |
| Muscle growth | No supporting evidence | Does not raise IGF-1 the way full hGH does |
| Metabolic improvement | Preliminary | Some animal data, no clear human confirmation |
Dosing, Frequency, and Cycle Length
Research and community protocols usually describe 250 to 500 mcg injected subcutaneously once per day, with some people starting near 300 mcg. The aod-9604 5mg dosage is common because a 5 mg vial lasts roughly 10 to 20 days at those amounts.
People often ask how often do you take aod 9604; most protocols use one daily injection, and a few split the dose into two smaller shots. Whether to inject near meals or on an empty stomach is debated, and no human study has settled the question.
A typical aod 9604 cycle length in non-clinical reports runs 8 to 12 weeks followed by a break. Because there is no approved protocol, any cycle length is experimental, and sterile technique matters as much as the dose.
How AOD-9604 Compares to Other Peptides
Two peptides often mentioned alongside AOD-9604 are tesamorelin and MOTS-c. They work through different mechanisms and have different regulatory statuses.
| Peptide | Primary researched use | FDA status | Typical research dose |
|---|---|---|---|
| AOD-9604 | Fat loss | Not approved | 250 to 500 mcg daily |
| Tesamorelin | Visceral fat in HIV lipodystrophy | Approved for that one indication | 1 to 2 mg daily |
| MOTS-c | Metabolic regulation | Not approved | 5 to 10 mg weekly in community reports |
Tesamorelin is the only one of the three with FDA approval, and only for a specific condition. When people compare aod 9604 vs mots-c, the key difference is mechanism: AOD-9604 targets lipolysis directly, while MOTS-c is studied for mitochondrial and metabolic effects. Stacking AOD-9604 with tesamorelin has not been tested for safety in humans.
Legal Status and Practical Cautions
AOD-9604 is not approved by the FDA for any human use. It is sold as a research chemical, which means it is not held to the purity, labeling, and manufacturing standards that apply to prescription drugs.
Buying peptides from unregulated sellers carries real risk, including incorrect dosing, bacterial contamination, and undisclosed ingredients. Anyone who is pregnant or breastfeeding, has a medical condition, or takes prescription medication should talk with a healthcare professional before using any peptide.
AOD-9604 may look appealing for fat loss, but current evidence supports only modest effects, and long-term safety data do not exist. Well-studied approaches such as nutrition, resistance training, sleep, and clinician-guided treatment remain the foundation of lasting fat loss.
Frequently Asked Questions
Is AOD-9604 FDA-approved?
No, AOD-9604 is not FDA-approved for human use in the United States. It is sold as a research chemical and has not completed the large clinical trials required for prescription approval. Tesamorelin is the only related fat-loss peptide with FDA approval, and only for one specific condition.
What are the side effects of AOD-9604?
Reported side effects in small human trials include injection-site reactions, headache, nausea, and fatigue. Serious or long-term effects are unknown because no large safety studies have been completed. Anyone who develops a rash, swelling, or trouble breathing should seek medical care right away.
How much AOD-9604 do you take per day?
Research and community protocols commonly describe 250 to 500 mcg injected subcutaneously once daily. At those amounts, a 5 mg vial typically lasts about 10 to 20 days. Because AOD-9604 is not an approved drug, there is no official or FDA-endorsed dosing schedule.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.